|
|
|
|
Vol. 58, Issue 4, 778-787, October 2000
Biophysics Sector (R.A.G., E.M.S., S.D.A., A.S., M.V.T., A.N.) and
INFM Unit (E.M.S., S.D.A., A.N.), International School for Advanced
Studies (SISSA), Trieste, Italy; Department of Physiology, Kazan
Medical University, Kazan, Tatarstan, Russia (R.A.G., M.V.T.); and
Department of Biophysics, Kazan State University, Kazan, Tatarstan,
Russia (A.S.)
The mechanism responsible for the blocking action of mecamylamine on
neuronal nicotinic acetylcholine receptors (nAChRs) was studied on rat
isolated chromaffin cells recorded under whole-cell patch clamp.
Mecamylamine strongly depressed (IC50 = 0.34 µM) inward currents elicited by short pulses of nicotine, an effect slowly
reversible on wash. The mecamylamine block was voltage-dependent and
promptly relieved by a protocol combining membrane depolarization with
a nicotine pulse. Either depolarization or nicotine pulses were
insufficient per se to elicit block relief. Block relief was transient;
response depression returned in a use-dependent manner. Exposure to
mecamylamine failed to block nAChRs if they were not activated by
nicotine or if they were activated at positive membrane potentials.
These data suggest that mecamylamine could not interact with receptors
either at rest or at depolarized level. Other nicotinic antagonists
like dihydro-
-erythroidine or tubocurarine did not share this action
of mecamylamine although proadifen partly mimicked it. Mecamylamine is
suggested to penetrate and block open nAChRs that would subsequently
close and trap this antagonist. Computer modeling indicated that the
mechanism of mecamylamine blocking action could be described by
assuming that 1) mecamylamine-blocked receptors possessed a much
slower, voltage-dependent isomerization rate, 2) the rate constant for
mecamylamine unbinding was large and poorly voltage dependent. Hence,
channel reopening plus depolarization allowed mecamylamine escape and
block relief. In the presence of mecamylamine, therefore, nAChRs
acquire the new property of operating as coincidence detectors for
concomitant changes in membrane potential and receptor occupancy.
This article has been cited by other articles:
![]() |
Y. Teper, D. Whyte, E. Cahir, H. A. Lester, S. R. Grady, M. J. Marks, B. N. Cohen, C. Fonck, T. McClure-Begley, J. M. McIntosh, et al. Nicotine-Induced Dystonic Arousal Complex in a Mouse Line Harboring a Human Autosomal-Dominant Nocturnal Frontal Lobe Epilepsy Mutation J. Neurosci., September 19, 2007; 27(38): 10128 - 10142. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Boorman, M. Beato, P. J. Groot-Kormelink, S. D. Broadbent, and L. G. Sivilotti The Effects of {beta}3 Subunit Incorporation on the Pharmacology and Single Channel Properties of Oocyte-expressed Human {alpha}3{beta}4 Neuronal Nicotinic Receptors J. Biol. Chem., November 7, 2003; 278(45): 44033 - 44040. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Skorinkin, A. Nistri, and R. Giniatullin Bimodal Action of Protons on ATP Currents of Rat PC12 Cells J. Gen. Physiol., June 30, 2003; 122(1): 33 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Di Angelantonio, V. Costa, P. Carloni, L. Messori, and A. Nistri A Novel Class of Peptides with Facilitating Action on Neuronal Nicotinic Receptors of Rat Chromaffin Cells in Vitro: Functional and Molecular Dynamics Studies Mol. Pharmacol., January 1, 2002; 61(1): 43 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Papke, P. R. Sanberg, and R. D. Shytle Analysis of Mecamylamine Stereoisomers on Human Nicotinic Receptor Subtypes J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 646 - 656. [Abstract] [Full Text] |
||||